AMLo qualitative study of patient and clinician views
Research type
Research Study
Full title
Innovative prognostic test for early stage cutaneous melanoma (AMLo): qualitative study of patient and clinician views.
IRAS ID
251368
Contact name
Penny Lovat
Contact email
Sponsor organisation
South Tees Hospitals NHS Foundation Trust
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
STUDY AIMS:
1. Identify what may help or hinder the adoption of a novel test (to determine with more certainty high and low risk Stage 1 melanoma) from the perspectives of patients, carers and clinicians
2. Inform the route to the adoption of the test by the NHS and the commercialisation stage
PATIENTS AND SETTING: Up to 30 patients (and small number of carers) will be recruited from a hospital and up to 30 clinicians through melanoma professional groups
STUDY DESIGN AND DATA COLLECTION: This is a qualitative study using in-depth (telephone) interviews. Patients (and carers) will be given an information pack containing study information sheet, reply slip and pre-paid envelope. If interested in discussing the study further they will complete the slip with their name and contact detail and return directly to the researcher. The researcher will make contact to answer any questions about the study before the patient decides if they would like to participate in an interview. If they do decide to participate a convenient date and time will be arranged.
The leads of two melanoma professional groups will introduce the researcher to members. If they are happy to take part a convenient date and time will be arranged for a telephone interview.
Telephone consent will be sought just prior to the interview. A topic guide will be used in the interview to ensure the important points are covered but interviewees will be given the opportunity to raise issues they consider important related to melanoma and its diagnosis. Interviews will be audio recorded with permission.
ANALYSIS: The interview recordings will be transcribed and analysed. Analysis entails looking for common themes and patterns in the data within and across each group of patients, carers and clinicians.
DISSEMINATION: Participants will be informed of the findings in a short report.REC name
East of England - Cambridge East Research Ethics Committee
REC reference
19/EE/0018
Date of REC Opinion
11 Feb 2019
REC opinion
Further Information Favourable Opinion